Dr. Reddy's Laboratories Limited (DRREDDY.NS)
Manufactures generic drugs and pharmaceutical ingredients sold globally across multiple therapeutic areas.
1,142.30+0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-6.4%
The outlook
Dr. Reddy's is trading near the lower end of its 52-week range and below both its 50- and 200-day moving averages, signaling weakness in near-term momentum. Analyst consensus leans Hold with an average target sitting about 11% above the current price. The stock carries a trailing P/E of 28.7 and shows a bearish lean overall.
What’s behind the score
Analyst consensusHold — 2.9 avg of 40 analysts
Price trendBelow its 50- & 200-day averages
52-week range13% of the way from its 52-week low to high
Price targetAvg target +11% vs current price
Analyst price target
~12-month · 40 analysts1,262.63average target+10.5% vs now
Now 1,142.30
Low 1,039.00High 1,740.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$951.54B
52-wk high
1,414.90
52-wk low
1,101.00
50-day avg
1,280.31
200-day avg
1,263.48
Trailing P/E
28.7